Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ovarian Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 13941
Tytuł:
Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.
Autorzy:
Li N; Department of Gynecology and Obstetrics, First Affiliated Hospital, Jilin University, Jilin, P. R. China.
Jin S; Department of Oncology, General Hospital of Northern Theater Command, Dalian Medical University, Shenyang, P. R. China.
Wu J; Department of Oncology, General Hospital of Northern Theater Command, Dalian Medical University, Shenyang, P. R. China.
Ji H; Department of Oncology, General Hospital of Northern Theater Command, Jinzhou Medical University, Shenyang, P. R. China.
Du C; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Liu B; Department of Oncology, General Hospital of Northern Theater Command, Shenyang, P. R. China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 18; Vol. 19 (4), pp. e0299504. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/pathology
Liver Neoplasms*
Humans ; Female ; Retrospective Studies ; Proportional Hazards Models ; Risk Factors ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Integration of single-cell RNA-seq and bulk RNA-seq data to construct and validate a cancer-associated fibroblast-related prognostic signature for patients with ovarian cancer.
Autorzy:
Shen L; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, 67 Dongchang West Road, Liaocheng, Shandong, 252000, P.R. China.; Shandong University, Jinan, P.R. China.; Department of Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, Shandong, 250021, P.R. China.
Li A; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, 67 Dongchang West Road, Liaocheng, Shandong, 252000, P.R. China. .
Cui J; Department of Oral and Maxillofacial Surgery, Jinan Stomatology Hospital, 101 Jingliu Road, Jinan, Shandong, 250001, P.R. China.; Central Laboratory of Jinan Stamotological Hospital, Jinan Key Laboratory of Oral Tissue Regeneration, 101 Jingliu Road, Jinan, Shandong, 250001, P.R. China.
Liu H; Department of Obstetrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwuweiqi Road, Jinan, Shandong, 250021, P.R. China.
Zhang S; Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P.R. China. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Apr 16; Vol. 17 (1), pp. 82. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*
Ovarian Neoplasms*/genetics
Humans ; Female ; Prognosis ; Single-Cell Gene Expression Analysis ; RNA-Seq ; Tumor Microenvironment/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comprehensive DNA methylation profiling by MeDIP-NGS identifies potential genes and pathways for epithelial ovarian cancer.
Autorzy:
Gautam P; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, 211004, India.
Gupta S; Department of Surgical Oncology, King George Medical University, Lucknow, India.
Sachan M; Department of Biotechnology, Motilal Nehru National Institute of Technology, Allahabad, Prayagraj, 211004, India. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Apr 16; Vol. 17 (1), pp. 83. Date of Electronic Publication: 2024 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
DNA Methylation*/genetics
Ovarian Neoplasms*/genetics
Humans ; Female ; Carcinoma, Ovarian Epithelial/genetics ; CpG Islands ; Carcinogenesis/genetics ; RNA Polymerase III/genetics ; Protein Serine-Threonine Kinases/genetics ; Intracellular Signaling Peptides and Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition.
Autorzy:
Gorji-Bahri G; Department of Translational Medicine, Lund University, Malmö, Sweden.
Krishna BM; Department of Translational Medicine, Lund University, Malmö, Sweden.
Hagerling C; Department of Experimental Medical Science, Lund University, Lund, Sweden.
Orimo A; Department of Pathology and Oncology, Juntendo University, Tokyo, Japan.
Jirström K; Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Papadakos KS; Department of Translational Medicine, Lund University, Malmö, Sweden.
Blom AM; Department of Translational Medicine, Lund University, Malmö, Sweden. .; Division of Medical Protein Chemistry, Department of Translational Medicine, Lund University, Malmö, Sweden. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Apr 13; Vol. 22 (1), pp. 351. Date of Electronic Publication: 2024 Apr 13.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*
Humans ; Animals ; Mice ; Female ; Cartilage Oligomeric Matrix Protein ; Receptor, Notch3 ; Carcinogenesis ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.
Autorzy:
Chen Z; Department of Medicine, Xinglin College, Nantong University, Nantong City, Jiangsu Province, China.
Wang C; Department of Medicine, Xinglin College, Nantong University, Nantong City, Jiangsu Province, China.
Ding J; Department of Medicine, Xinglin College, Nantong University, Nantong City, Jiangsu Province, China.
Yu T; Department of Gynecology, Taicang Affiliated Hospital of Soochow University (The First People's Hospital of Taicang), Suzhou City, Jiangsu Province, China.
Li N; Department of Gynecology, Taicang Affiliated Hospital of Soochow University (The First People's Hospital of Taicang), Suzhou City, Jiangsu Province, China.
Ye C; Department of Gynecology, Taicang Affiliated Hospital of Soochow University (The First People's Hospital of Taicang), Suzhou City, Jiangsu Province, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 11; Vol. 19 (4), pp. e0291149. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
MicroRNAs*
Ovarian Neoplasms*/genetics
Male ; Female ; Humans ; Prognosis ; RNA, Circular/genetics ; RNA, Competitive Endogenous ; Endothelial Cells ; RNA, Messenger/genetics ; Gene Regulatory Networks
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study.
Autorzy:
Zhang L; Department of Reproductive Medicine, The First Affiliated Hospital of Ningbo University (Ningbo First Hospital), Ningbo University, Ningbo, 315000, Zhejiang, People's Republic of China.
Yan H; Department of Urology, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, 315000, Zhejiang, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8382. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Journal Article
MeSH Terms:
Endometriosis*/genetics
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/genetics
Carcinoma, Endometrioid*
Female ; Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Carcinoma, Ovarian Epithelial
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Development and validation of an ultrasound-based deep learning radiomics nomogram for predicting the malignant risk of ovarian tumours.
Autorzy:
Du Y; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Xiao Y; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Guo W; Department of Pathology, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Yao J; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Lan T; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Li S; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Wen H; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Zhu W; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
He G; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China.
Zheng H; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China. .
Chen H; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region and Guangxi Academy of Medical Sciences, No. 6 Taoyuan Road, Qingxiu District, Nanning, 530021, China. .
Pokaż więcej
Źródło:
Biomedical engineering online [Biomed Eng Online] 2024 Apr 09; Vol. 23 (1), pp. 41. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Deep Learning*
Ovarian Neoplasms*/diagnostic imaging
Humans ; Female ; Nomograms ; Radiomics ; Ultrasonography ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient.
Autorzy:
Bhaskari J; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; National Centre for Biological Sciences, GKVK campus, Bangalore, Karnataka, India.
Bhagat R; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; Oncostem Diagnostic Pvt Ltd, Bangalore, Karnataka, India.
Shilpa V; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.; Department of Biochemistry, Sri Shankara Cancer Hospital and Research Centre, Bangalore, 560004, Karnataka, India.
Premalata CS; Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India.
Krishnamoorthy L; Department of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India. .; Department of Biochemistry, Sri Shankara Cancer Hospital and Research Centre, Bangalore, 560004, Karnataka, India. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Apr 09; Vol. 17 (1), pp. 77. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/pathology
Humans ; Female ; Carcinoma, Ovarian Epithelial/pathology ; Prognosis ; Cyclooxygenase 2/metabolism ; Vascular Endothelial Growth Factor C ; Ki-67 Antigen ; Nitric Oxide ; Neoplasm Staging ; Biomarkers, Tumor/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.
Autorzy:
Lashen A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Department of Pathology, Nottingham University Hospital, City Campus, Nottingham NG5 1PB, UK.
Algethami M; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Alqahtani S; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Shoqafi A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Sheha A; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Jeyapalan JN; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Faculty of Medicine and Health Sciences, Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.
Mongan NP; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Faculty of Medicine and Health Sciences, Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington LE12 5RD, UK.; Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA.
Rakha EA; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.
Madhusudan S; Naaz Coker Ovarian Cancer Research Centre, Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK.; Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 05; Vol. 25 (7). Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Retinoblastoma*
Ovarian Neoplasms*/genetics
Retinal Neoplasms*
Female ; Humans ; Carcinoma, Ovarian Epithelial ; Cyclin D1/genetics ; Cyclin-Dependent Kinase 2/genetics ; Ubiquitin-Protein Ligases ; Retinoblastoma Binding Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer.
Autorzy:
Kim YN; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Chung YS; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Park E; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Lee ST; Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee JY; Department of Obstetrics and Gynecology, Institute of Women's Life Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 05; Vol. 14 (1), pp. 7992. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/genetics
Ovarian Neoplasms*/pathology
Receptor, ErbB-2*/metabolism
Female ; Humans ; Mutation ; Mutation Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
Autorzy:
Mehra T; Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
Lupatsch JE; Department of Public Health, Institute of Pharmaceutical Medicine (ECPM) and Health Economics Facility, University of Basel, Basel, Switzerland.
Kössler T; Service d'oncologie, Hôpitaux Universitaires Genève, Genève, Switzerland.
Dedes K; Breast Cancer Center Zürichsee, Zurich, Switzerland.
Siebenhüner AR; Onkozentrum Hirslanden Zurich AG and University of Zurich, Zurich, Switzerland.
von Moos R; Department of Medical Oncology and Hematology, Cantonal Hospital of Graubünden, Chur, Switzerland.
Wicki A; Department of Medical Oncology and Hematology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.
Schwenkglenks ME; Department of Public Health and Head of Research, Health Economics Facility, Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0301271. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*/genetics
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Piperazines*
Female ; Humans ; BRCA1 Protein/genetics ; Platinum/therapeutic use ; BRCA2 Protein/genetics ; Phthalazines/therapeutic use ; Germ Cells/pathology ; Cost-Benefit Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
Autorzy:
Al-Alem L; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.
Prendergast JM; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.
Clark J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.
Zarrella B; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Zarrella DT; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Hill SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Department of Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Growdon WB; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.
Pooladanda V; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA.
Spriggs DR; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.
Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Elias KM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Nazer RI; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.
Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, MA, 02114, USA.
Behrens J; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.
Dransfield DT; Siamab Therapeutics, Inc, Newton, MA, 02458, USA.
Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. .; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, 02115, USA. .; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Apr 02; Vol. 17 (1), pp. 71. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Ovarian Neoplasms*
Genital Neoplasms, Female*
Humans ; Female ; Antigens, Tumor-Associated, Carbohydrate/metabolism ; CA-125 Antigen ; Enzyme-Linked Immunosorbent Assay ; Biomarkers, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells.
Autorzy:
Lee J; WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea.; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Jang S; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Im J; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Han Y; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Kim S; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Paul F. Glenn Laboratories for the Biology of Aging, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jo H; WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea.; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Wang W; Department of Medical Oncology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Cho U; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Kim SI; Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Seol A; Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Republic of Korea.; Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Republic of Korea.
Kim B; Department of SmartBio, College of Life and Health Science, Kyungsung University, Busan, Republic of Korea.
Song YS; WCU Biomodulation, Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea. .; Cancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea. .; Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Republic of Korea. .; Department of Obstetrics and Gynecology, Myongji Hospital, Hanyang University College of Medicine, Goyang, Republic of Korea. .
Pokaż więcej
Źródło:
Journal of ovarian research [J Ovarian Res] 2024 Apr 02; Vol. 17 (1), pp. 73. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Stearoyl-CoA Desaturase*/metabolism
Ovarian Neoplasms*
Female ; Humans ; Apoptosis ; Endoplasmic Reticulum Stress ; Carcinoma, Ovarian Epithelial ; Lipids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report.
Autorzy:
Yoshida H; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Hiranuma K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
Nakahara M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Kobayashi-Kato M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Tanase Y; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Uno M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.
Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Kato T; Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 394-400. Date of Electronic Publication: 2023 May 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Ovarian Neoplasms*/diagnosis
Adenocarcinoma*
Humans ; Female ; Middle Aged ; Young Adult ; Adult ; Hyperplasia ; Biopsy, Needle ; Germ Cells ; AMP-Activated Protein Kinase Kinases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 13941

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies